Source: International Congress 2017 – Current challenges in COPD evaluation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. de Blasio (Pozzuoli, NA, Italy). Malnutrition and sarcopenia in chronic obstructive pulmonary disease according to the new ESPEN definition and EWGSOP criteria. 400

Member's Comments

No comment yet.

Related content which might interest you: Recommendations of the ATS/ERS Task Force for the definition of outcomes for COPD pharmacological trials Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Osteoporosis, sarcopenia and pulmonary hypertension in relation to GOLD classification vs BODE index in COPD Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Do GOLD stages of COPD severity really correspond to differences in health status? Source: Eur Respir J 2003; 22: 444-449 Year: 2003 Hypertension in chronic obstructive pulmonary disease (COPD): A review of current practice Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Monitoring of COPD. A review of current guidelines‘ recommendations Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Management of chronic obstructive pulmonary disease: compliance with the Swiss guidelines Source: Eur Respir J 2004; 24: Suppl. 48, 13s Year: 2004 Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Dietary habits in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013 Socioeconomic status shaping GOLD A-D classification in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Obesity and impairments in chronic obstruction pulmonary disease (COPD) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Chronic obstructive pulmonary disease an underperceived disease: the PLATINO study Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD Year: 2008 Nutritional status in chronic obstructive pulmonary disease Source: International Congress 2014 – Comorbidities Year: 2014 Chronic obstructive pulmonary disease (COPD) assessment service: guidelines for referral and accuracy of clinical assessment Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005 Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Chronic obstructive pulmonary disease and myocardial infarction: Special aspects of clinical course in comorbid conditions Source: International Congress 2014 – Predictors Year: 2014 Frequency of depression in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014